Cargando…
T-cell activation, senescence, and exhaustion in asymptomatic HIV/Leishmania infantum co-infection
BACKGROUND: Leishmania infantum is an opportunistic parasitic infection. An immunocompromised state increases the risk of converting asymptomatic infection to symptomatic visceral leishmaniasis (VL), which has a ~5% fatality rate even with treatment. HIV coinfection increases the risk of death from...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029033/ https://www.ncbi.nlm.nih.gov/pubmed/36945413 http://dx.doi.org/10.1101/2023.03.06.23286828 |
_version_ | 1784910063271411712 |
---|---|
author | de Oliveira Mendes-Aguiar, Carolina do Monte Alves, Manoella de Albuquerque Lopes Machado, Amanda de Góis Monteiro, Glória Regina Medeiros, Iara Marques Queiroz, Jose Wilton Lima, Iraci Duarte Pearson, Richard D. Wilson, Mary E. Glesby, Marshall J. do Nascimento, Eliana Lúcia Tomaz Jerônimo, Selma Maria Bezerra |
author_facet | de Oliveira Mendes-Aguiar, Carolina do Monte Alves, Manoella de Albuquerque Lopes Machado, Amanda de Góis Monteiro, Glória Regina Medeiros, Iara Marques Queiroz, Jose Wilton Lima, Iraci Duarte Pearson, Richard D. Wilson, Mary E. Glesby, Marshall J. do Nascimento, Eliana Lúcia Tomaz Jerônimo, Selma Maria Bezerra |
author_sort | de Oliveira Mendes-Aguiar, Carolina |
collection | PubMed |
description | BACKGROUND: Leishmania infantum is an opportunistic parasitic infection. An immunocompromised state increases the risk of converting asymptomatic infection to symptomatic visceral leishmaniasis (VL), which has a ~5% fatality rate even with treatment. HIV coinfection increases the risk of death from VL. METHODS: A cross-sectional study was performed between 2014 and 2016 to determine the prevalence of L. infantum infection in HIV positive subjects residing in the state of Rio Grande do Norte, Brazil (n=1,372) and of these a subgroup of subjects were followed longitudinally. Subsequent incident cases of VL were ascertained from a public health database through 2018. A subgroup (n=69) of the cross-sectional study subjects was chosen to assess immune status (T cell activation, senescence, exhaustion) and outcome. The data were compared between asymptomatic HIV+/L. infantum+ (HIV/Leish), symptomatic visceral leishmaniasis (VL), recovered VL, DTH+ (Delayed-Type Hypersensitivity response – Leishmanin skin test), AIDS/VL, HIV+ only (HIV+), and Non-HIV/Non L. infantum infection (control subjects). RESULTS: The cross-sectional study showed 24.2% of HIV+ subjects had positive anti-IgG Leishmania antibodies. After 3 years, 2.4% (8 of 333) of these HIV/Leish coinfected subjects developed AIDS/VL, whereas 1.05% (11 of 1,039) of HIV subjects with negative leishmania serology developed AIDS/VL. Poor adherence to antiretroviral therapy (p=0.0008) or prior opportunistic infections (p=0.0007) was associated with development of AIDS/VL. CD4+ (p=0.29) and CD8+ (p=0.38) T cells counts or viral load (p=0.34) were similar between asymptomatic HIV/Leish and HIV subjects. However, activated CD8(+)CD38(+)HLA-DR(+) T cells were higher in asymptomatic HIV/Leish than HIV group. Likewise, senescent (CD57+) or exhausted (PD1(+)) CD8(+) T cells were higher in asymptomatic HIV/Leish than in AIDS/VL or HIV groups. CONCLUSION: Although asymptomatic HIV/Leish subjects had normal and similar CD4+ and CD8+ T cells counts, their CD8(+)T cells had increased activation, senescence, and exhaustion, which could contribute to risk of developing VL. |
format | Online Article Text |
id | pubmed-10029033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-100290332023-03-22 T-cell activation, senescence, and exhaustion in asymptomatic HIV/Leishmania infantum co-infection de Oliveira Mendes-Aguiar, Carolina do Monte Alves, Manoella de Albuquerque Lopes Machado, Amanda de Góis Monteiro, Glória Regina Medeiros, Iara Marques Queiroz, Jose Wilton Lima, Iraci Duarte Pearson, Richard D. Wilson, Mary E. Glesby, Marshall J. do Nascimento, Eliana Lúcia Tomaz Jerônimo, Selma Maria Bezerra medRxiv Article BACKGROUND: Leishmania infantum is an opportunistic parasitic infection. An immunocompromised state increases the risk of converting asymptomatic infection to symptomatic visceral leishmaniasis (VL), which has a ~5% fatality rate even with treatment. HIV coinfection increases the risk of death from VL. METHODS: A cross-sectional study was performed between 2014 and 2016 to determine the prevalence of L. infantum infection in HIV positive subjects residing in the state of Rio Grande do Norte, Brazil (n=1,372) and of these a subgroup of subjects were followed longitudinally. Subsequent incident cases of VL were ascertained from a public health database through 2018. A subgroup (n=69) of the cross-sectional study subjects was chosen to assess immune status (T cell activation, senescence, exhaustion) and outcome. The data were compared between asymptomatic HIV+/L. infantum+ (HIV/Leish), symptomatic visceral leishmaniasis (VL), recovered VL, DTH+ (Delayed-Type Hypersensitivity response – Leishmanin skin test), AIDS/VL, HIV+ only (HIV+), and Non-HIV/Non L. infantum infection (control subjects). RESULTS: The cross-sectional study showed 24.2% of HIV+ subjects had positive anti-IgG Leishmania antibodies. After 3 years, 2.4% (8 of 333) of these HIV/Leish coinfected subjects developed AIDS/VL, whereas 1.05% (11 of 1,039) of HIV subjects with negative leishmania serology developed AIDS/VL. Poor adherence to antiretroviral therapy (p=0.0008) or prior opportunistic infections (p=0.0007) was associated with development of AIDS/VL. CD4+ (p=0.29) and CD8+ (p=0.38) T cells counts or viral load (p=0.34) were similar between asymptomatic HIV/Leish and HIV subjects. However, activated CD8(+)CD38(+)HLA-DR(+) T cells were higher in asymptomatic HIV/Leish than HIV group. Likewise, senescent (CD57+) or exhausted (PD1(+)) CD8(+) T cells were higher in asymptomatic HIV/Leish than in AIDS/VL or HIV groups. CONCLUSION: Although asymptomatic HIV/Leish subjects had normal and similar CD4+ and CD8+ T cells counts, their CD8(+)T cells had increased activation, senescence, and exhaustion, which could contribute to risk of developing VL. Cold Spring Harbor Laboratory 2023-03-06 /pmc/articles/PMC10029033/ /pubmed/36945413 http://dx.doi.org/10.1101/2023.03.06.23286828 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article de Oliveira Mendes-Aguiar, Carolina do Monte Alves, Manoella de Albuquerque Lopes Machado, Amanda de Góis Monteiro, Glória Regina Medeiros, Iara Marques Queiroz, Jose Wilton Lima, Iraci Duarte Pearson, Richard D. Wilson, Mary E. Glesby, Marshall J. do Nascimento, Eliana Lúcia Tomaz Jerônimo, Selma Maria Bezerra T-cell activation, senescence, and exhaustion in asymptomatic HIV/Leishmania infantum co-infection |
title | T-cell activation, senescence, and exhaustion in asymptomatic HIV/Leishmania infantum co-infection |
title_full | T-cell activation, senescence, and exhaustion in asymptomatic HIV/Leishmania infantum co-infection |
title_fullStr | T-cell activation, senescence, and exhaustion in asymptomatic HIV/Leishmania infantum co-infection |
title_full_unstemmed | T-cell activation, senescence, and exhaustion in asymptomatic HIV/Leishmania infantum co-infection |
title_short | T-cell activation, senescence, and exhaustion in asymptomatic HIV/Leishmania infantum co-infection |
title_sort | t-cell activation, senescence, and exhaustion in asymptomatic hiv/leishmania infantum co-infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029033/ https://www.ncbi.nlm.nih.gov/pubmed/36945413 http://dx.doi.org/10.1101/2023.03.06.23286828 |
work_keys_str_mv | AT deoliveiramendesaguiarcarolina tcellactivationsenescenceandexhaustioninasymptomatichivleishmaniainfantumcoinfection AT domontealvesmanoella tcellactivationsenescenceandexhaustioninasymptomatichivleishmaniainfantumcoinfection AT dealbuquerquelopesmachadoamanda tcellactivationsenescenceandexhaustioninasymptomatichivleishmaniainfantumcoinfection AT degoismonteirogloriaregina tcellactivationsenescenceandexhaustioninasymptomatichivleishmaniainfantumcoinfection AT medeirosiaramarques tcellactivationsenescenceandexhaustioninasymptomatichivleishmaniainfantumcoinfection AT queirozjosewilton tcellactivationsenescenceandexhaustioninasymptomatichivleishmaniainfantumcoinfection AT limairaciduarte tcellactivationsenescenceandexhaustioninasymptomatichivleishmaniainfantumcoinfection AT pearsonrichardd tcellactivationsenescenceandexhaustioninasymptomatichivleishmaniainfantumcoinfection AT wilsonmarye tcellactivationsenescenceandexhaustioninasymptomatichivleishmaniainfantumcoinfection AT glesbymarshallj tcellactivationsenescenceandexhaustioninasymptomatichivleishmaniainfantumcoinfection AT donascimentoelianaluciatomaz tcellactivationsenescenceandexhaustioninasymptomatichivleishmaniainfantumcoinfection AT jeronimoselmamariabezerra tcellactivationsenescenceandexhaustioninasymptomatichivleishmaniainfantumcoinfection |